LY404187 [Ligand Id: 4249] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL435582
  • GluA1/Glutamate receptor ionotropic, AMPA 1 in Human [ChEMBL: CHEMBL2009] [GtoPdb: 444] [UniProtKB: P42261]
There should be some charts here, you may need to enable JavaScript!
  • GluA2/Glutamate receptor ionotropic, AMPA 2 in Human [ChEMBL: CHEMBL4016] [GtoPdb: 445] [UniProtKB: P42262]
There should be some charts here, you may need to enable JavaScript!
  • GluA3/Glutamate receptor ionotropic, AMPA 3 in Human [ChEMBL: CHEMBL3595] [GtoPdb: 446] [UniProtKB: P42263]
There should be some charts here, you may need to enable JavaScript!
  • GluA4/Glutamate receptor ionotropic, AMPA 4 in Human [ChEMBL: CHEMBL3190] [GtoPdb: 447] [UniProtKB: P48058]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
GluA1/Glutamate receptor ionotropic, AMPA 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2009] [GtoPdb: 444] [UniProtKB: P42261]
ChEMBL Inhibition of GluR1 expressed in HEK cells B 5.25 pEC50 5650 nM EC50 J Med Chem (2010) 53: 7271-7279 [PMID:20839777]
GtoPdb - - 5.25 pEC50 5650 nM EC50 Neuropharmacology (2001) 40: 976-83 [PMID:11406188]
GluA2/Glutamate receptor ionotropic, AMPA 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4016] [GtoPdb: 445] [UniProtKB: P42262]
ChEMBL Activity against human GLUR2 flop expressed in HEK293 cells assessed as glutamate-stimulated calcium influx by FLIPR assay F 5.72 pEC50 1905 nM EC50 Bioorg Med Chem Lett (2006) 16: 5057-5061 [PMID:16879964]
ChEMBL Inhibition of GluR2 flop expressed in HEK cells B 5.84 pEC50 1440 nM EC50 J Med Chem (2010) 53: 7271-7279 [PMID:20839777]
ChEMBL Activity against human GLUR2 flip expressed in HEK293 cells assessed as glutamate-stimulated calcium influx by FLIPR assay F 6.25 pEC50 559 nM EC50 Bioorg Med Chem Lett (2006) 16: 5057-5061 [PMID:16879964]
GtoPdb - - 6.82 pEC50 150 nM EC50 Neuropharmacology (2001) 40: 976-83 [PMID:11406188]
ChEMBL Agonist activity at GluR2 receptor F 6.82 pEC50 150 nM EC50 J Med Chem (2010) 53: 7271-7279 [PMID:20839777]
GluA3/Glutamate receptor ionotropic, AMPA 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3595] [GtoPdb: 446] [UniProtKB: P42263]
ChEMBL Inhibition of GluR3 expressed in HEK cells B 5.78 pEC50 1660 nM EC50 J Med Chem (2010) 53: 7271-7279 [PMID:20839777]
GtoPdb - - 5.78 pEC50 1660 nM EC50 Neuropharmacology (2001) 40: 976-83 [PMID:11406188]
GluA4/Glutamate receptor ionotropic, AMPA 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3190] [GtoPdb: 447] [UniProtKB: P48058]
ChEMBL Activity against human GLUR4 flop expressed in HEK293 cells assessed as glutamate-stimulated calcium influx by FLIPR assay F 5.97 pEC50 1061 nM EC50 Bioorg Med Chem Lett (2006) 16: 5057-5061 [PMID:16879964]
ChEMBL Activity against human GLUR4 flip expressed in HEK293 cells assessed as glutamate-stimulated calcium influx by FLIPR assay F 6.38 pEC50 420 nM EC50 Bioorg Med Chem Lett (2006) 16: 5057-5061 [PMID:16879964]
ChEMBL Tested for potentiation towards human iGluR4 receptor expressed in HEK293 cells F 6.54 pEC50 290 nM EC50 J Med Chem (2000) 43: 4354-4358 [PMID:11087558]
ChEMBL Potentiation of responses mediated by 100 uM L-glutamate in transfected HEK293 cells expressing human homomeric iGluR4 flip receptors. F 6.54 pEC50 290 nM EC50 J Med Chem (2002) 45: 2101-2111 [PMID:11985477]
ChEMBL Inhibition of GluR4 expressed in HEK293 cells B 6.54 pEC50 290 nM EC50 J Med Chem (2010) 53: 7271-7279 [PMID:20839777]
GtoPdb - - 6.68 pEC50 210 nM EC50 Neuropharmacology (2001) 40: 976-83 [PMID:11406188]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]